New - FDA not giving approval to Emfit for nighttime bed seizure alarm?
 Loading
|
Take control of your epilepsy and seizures. Seizure management has never been easier.
TAKE CONTROL TODAYCarbamazepine is a first-line treatment and FDA-approved for trigeminal neuralgia. It also is used to treat glossopharyngeal neuralgia and painful peripheral neuropathy (particularly due to diabetes).
The use of carbamazepine in the management of patients with acute mania is supported by a number of studies, which have found it similar in effectiveness to lithium.
The literature also supports the use of carbamazepine for long-term prophylaxis of bipolar disorder, particularly for rapid cyclers.
It is sometimes used for other psychiatric disorders and diabetes insipidus, but few studies have been performed to confirm its effectiveness for those conditions.
Welcome to the Wiki. This space is created for epilepsy.com members to share their own experiences and expertise to help refine and expand the discussion around important topics.
No members have yet contributed to this topic. If you are not yet an epilepsy.com member, register today to get started on this Wiki topic and the many other advantages of being a member. If you are a member and wish to be the first to edit this Wiki topic, please make sure to login, then click on the orange "Start Wiki" button at the top of this page. Or, learn more about Wikis.
|
New - FDA not giving approval to Emfit for nighttime bed seizure alarm?
Created by at3/5/08 - 4:06 pm|3 Comments |